Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome

The aim of this study was to investigate the effects of a 6-month treatment with intragastric balloon (IGB) on body composition and depressive/anxiety symptoms in obese individuals with metabolic syndrome (MS). Fifty patients (aged 18-50 years) with obesity and MS were selected for treatment with IG...

Full description

Saved in:
Bibliographic Details
Published in:Diabetology and metabolic syndrome 2016-12, Vol.8 (1), p.81-81, Article 81
Main Authors: Guedes, Erika P, Madeira, Eduardo, Mafort, Thiago T, Madeira, Miguel, Moreira, Rodrigo O, Mendonça, Laura Maria C, Godoy-Matos, Amélio F, Lopes, Agnaldo J, Farias, Maria Lucia F
Format: Article
Language:English
Subjects:
Complications and side effects
Mental illness
Methods
Obesity
Psychological aspects
Risk factors
Weight loss
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to investigate the effects of a 6-month treatment with intragastric balloon (IGB) on body composition and depressive/anxiety symptoms in obese individuals with metabolic syndrome (MS). Fifty patients (aged 18-50 years) with obesity and MS were selected for treatment with IGB for 6 months. Body composition was verified with dual-energy X-ray absorptiometry (DXA) at baseline and right after IGB removal. Anxiety/depressive symptoms were assessed with the Beck Depression Inventory (BDI) and the hospital anxiety and depression scale (HADS) at baseline and after 6 months of treatment. In total, 39 patients completed the study. After 6 months, there were significant decreases in weight (11.7 ± 9.6 kg, p 
ISSN:1758-5996
1758-5996
DOI:10.1186/s13098-016-0197-6